General Information of Drug (ID: DMR2FPO)

Drug Name
FK-584
Synonyms
4,4-Diphenylcyclopentenylamine hydrochloride; 2-Cyclopenten-1-amine, 4,4-diphenyl-, hydrochloride; 4,4-diphenyl-2-cyclopentenylamine; FK 584; 56740-43-3; AC1L57OZ; LS-58284; 4,4-diphenylcyclopent-2-en-1-amine hydrochloride
Indication
Disease Entry ICD 11 Status REF
Central and peripheral nervous disease 8A04-8E7Z Discontinued in Phase 2 [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 291.4
Logarithm of the Partition Coefficient (xlogp) 5
Rotatable Bond Count (rotbonds) 4
Hydrogen Bond Donor Count (hbonddonor) 1
Hydrogen Bond Acceptor Count (hbondacc) 1
Chemical Identifiers
Formula
C21H25N
IUPAC Name
(1S)-N-tert-butyl-4,4-diphenylcyclopent-2-en-1-amine
Canonical SMILES
CC(C)(C)N[C@H]1CC(C=C1)(C2=CC=CC=C2)C3=CC=CC=C3
InChI
InChI=1S/C21H25N/c1-20(2,3)22-19-14-15-21(16-19,17-10-6-4-7-11-17)18-12-8-5-9-13-18/h4-15,19,22H,16H2,1-3H3/t19-/m1/s1
InChIKey
QMTVTICJRCJOFZ-LJQANCHMSA-N
Cross-matching ID
PubChem CID
9947991
TTD ID
D0IJ2H

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Muscarinic acetylcholine receptor M5 (CHRM5) TTH18TF ACM5_HUMAN Modulator [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800006686)
2 US patent application no. 2005,0261,328, Pharmaceutical composition comprising beta-3-adrenoceptor-agonists and antimuscarinic agents.